Subcutaneous epcoritamab in combination with rituximab and lenalidomide in relapsed or refractory follicular lymphoma: Preliminary phase 1/2 results Meeting Abstract


Authors: Linton, K. M.; Wahlin, B.; Leppä, S.; Morschhauser, F.; Elliott, B.; Liu, T.; Stirner, M. C.; Abbas, A.; Falchi, L.
Abstract Title: Subcutaneous epcoritamab in combination with rituximab and lenalidomide in relapsed or refractory follicular lymphoma: Preliminary phase 1/2 results
Meeting Title: 62nd Annual Scientific Meeting of the British Society for Haematology
Journal Title: British Journal of Haematology
Volume: 197
Issue: Suppl. 1
Meeting Dates: 2022 Apr 3-5
Meeting Location: Manchester, United Kingdom
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2022-05-01
Start Page: 94
Language: English
ACCESSION: WOS:000776484300103
PROVIDER: wos
PUBMED: 35362090
DOI: 10.1111/bjh.18134
Notes: Meeting Abstract: BSH22-PO53 -- Hybrid meeting, also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lorenzo Falchi
    107 Falchi